Marianne Kearney
Overview
Explore the profile of Marianne Kearney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith A, Singleton J, Aperghis A, Coffey C, Creigh P, Cudkowicz M, et al.
JAMA Neurol
. 2023 Oct;
80(12):1334-1343.
PMID: 37870862
Importance: Cryptogenic sensory peripheral neuropathy (CSPN) is highly prevalent and often disabling due to neuropathic pain. Metabolic syndrome and its components increase neuropathy risk. Diet and exercise have shown promise...
2.
Marshall S, Taki S, Love P, Laird Y, Kearney M, Tam N, et al.
BMC Public Health
. 2021 Jun;
21(1):1159.
PMID: 34134674
Introduction: Healthy Beginnings is an established nurse-led early childhood obesity prevention program that promotes healthy infant feeding practices and active play in the early years of life. To improve engagement...
3.
Marshall S, Taki S, Love P, Laird Y, Kearney M, Tam N, et al.
BMC Public Health
. 2021 Feb;
21(1):284.
PMID: 33541310
Background: Behavioural interventions for the early prevention of childhood obesity mostly focus on English-speaking populations in high-income countries. Cultural adaptation is an emerging strategy for implementing evidence-based interventions among different...
4.
Naismith R, Bermel R, Coffey C, Goodman A, Fedler J, Kearney M, et al.
Neurology
. 2020 Dec;
96(4):e491-e500.
PMID: 33268562
Objective: To determine whether ibudilast has an effect on brain volume and new lesions in progressive forms of multiple sclerosis (MS). Methods: A randomized, placebo-controlled, blinded study evaluated ibudilast at...
5.
Marshall S, Taki S, Love P, Kearney M, Tam N, Sabry M, et al.
Women Birth
. 2020 Jul;
34(4):e346-e356.
PMID: 32600988
Optimal feeding practices can establish lifelong, transgenerational and global health benefits. Migration and cultural factors impact infant feeding practices and the support mothers receive for optimal infant feeding. This qualitative...
6.
Cudkowicz M, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, et al.
Lancet Neurol
. 2014 Oct;
13(11):1083-1091.
PMID: 25297012
Background: Glutamate excitotoxicity might contribute to the pathophysiology of amyotrophic lateral sclerosis. In animal models, decreased excitatory aminoacid transporter 2 (EAAT2) overexpression delays disease onset and prolongs survival, and ceftriaxone...
7.
Atassi N, Yerramilli-Rao P, Szymonifka J, Yu H, Kearney M, Grasso D, et al.
Neurology
. 2013 Sep;
81(15):1350-5.
PMID: 24005339
Objective: To investigate predictors of trial start-up times, high attrition, and poor protocol adherence in amyotrophic lateral sclerosis (ALS) trials. Methods: Retrospective analysis of start-up times, retention, and protocol adherence...
8.
Losordo D, Schatz R, White C, Udelson J, Veereshwarayya V, Durgin M, et al.
Circulation
. 2007 Jun;
115(25):3165-72.
PMID: 17562958
Background: A growing population of patients with coronary artery disease experiences angina that is not amenable to revascularization and is refractory to medical therapy. Preclinical studies have indicated that human...
9.
Egger M, Schgoer W, Beer A, Jeschke J, Leierer J, Theurl M, et al.
FASEB J
. 2007 May;
21(11):2906-17.
PMID: 17504977
Expression of angiogenic cytokines like vascular endothelial growth factor is enhanced by hypoxia. We tested the hypothesis that decreased oxygen levels up-regulate the angiogenic factor secretoneurin. In vivo, muscle cells...
10.
Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, et al.
Circulation
. 2006 Nov;
114(20):2163-9.
PMID: 17075009
Background: We compared the therapeutic potential of purified mobilized human CD34+ cells with that of mobilized total mononuclear cells (tMNCs) for the preservation/recovery of myocardial tissue integrity and function after...